Watch this EyeWire TV feature announcing BELKIN Vision's CE Mark
Feature: From Too Few Drops to DSLT - An Interview With Prof Gerd Auffarth
Health Supplement Feature: Vision of the future for Glaucoma
The State of SLT: Advancing the Technology and its Adoption
Interview: Professor Augusto Azuara-Blanco discusses glaucoma treatment in the blink of an eye
Interview: The Israeli Startup Treating the Silent Thief of Sight
Remote Diagnosis and Treatment of Glaucoma: DSLT's application in telemedicine
BELKIN Vision wins €17.5M from the EU Innovation Council
Watch CEO Daria Lemann Blumenthal in this interview on i24News about our disruptive DSLT glaucoma treatment.
Developing DSLT - Interview with Prof Michael Belkin
Let There Be (Laser) Light - How Updated EGS Guidelines Impact Market Adoption of our Technology
The Glaucoma Treatment That Only Takes Seconds
Listen to this podcast with CEO Daria Lemann Blumenthal about her journey as a woman in medtech.
Read this candid interview with CEO Daria Lemann-Blumenthal
Opinion piece on 'Glaucoma care in a matter of seconds'
Listen (in Hebrew) as Yaakov Eichler interviews Dr. Modi Goldenfeld about regular glaucoma exams and BELKIN Vision’s technology.
BELKIN Vision Completes $12.25 Series B Financing Round
BELKIN Vision Announces $12.2M Raised in Series B Funding
Pushing Boundaries with Advanced Technologies
Emerging Glaucoma Devices See Beyond IOP
BELKIN Vision COVID-19 update
New Technologies Change Glaucoma Treatment Paradigm
Glaucoma 360 forum provides Vision for 2020
Interview with CEO Daria Lemann-Blumenthall
US Edition Lindstrom's Opinion
Novel DSLT Taking aim at greater access to glaucoma care
Get our latest news and updates!
Subscribe to receive BELKIN Vision's Newsletter with the latest news and clinical updates.